Sunshine Lake Pharma Co., Ltd.

This study tests a new drug called crifortinib besylate combined with standard chemotherapy for adults who have not yet been treated for acute myeloid leukemia (AML). The goal is to see if the combination is safe and works better than chemo alone. About 133 adults aged 18 and old…

This study tests a new tablet called HEC585 in about 472 adults aged 40-80 with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. Participants are randomly assigned to receive HEC585, a placebo, or an existing drug (pirfenidone) to see …

This study tests whether an experimental drug called HEC585 can slow the worsening of lung function in people with progressive fibrosing interstitial lung disease, a condition where lung tissue becomes scarred and breathing gets harder over time. About 110 adults will receive eit…

This study tests a new drug called HEC73543 (Clifutinib) against standard chemotherapy in 324 adults with a specific type of acute myeloid leukemia (FLT3-ITD) that has come back or not responded to treatment. The goal is to see if the new drug helps people live longer and achieve…

This study tests a new drug called HEC169096 in people with advanced solid tumors, including thyroid cancer and non-small cell lung cancer. The drug targets a specific genetic change (RET mutation or fusion) that helps some cancers grow. The study has two parts: first finding the…

This early-stage study tests a new injection called HEC-007 to see if it is safe and how the body processes it. It involves 126 healthy adults and overweight or obese volunteers. Researchers will monitor side effects and measure changes in weight, waist size, and blood sugar leve…

This study tests a new drug called mitizodone phosphate for people with major depression. About 600 adults will receive either the drug or a placebo for 8 weeks. The goal is to see if the drug reduces depression symptoms better than a placebo and to find the best dose.

This early-stage study tests a new medicine called HEC169584 in 96 healthy adults aged 18 to 45. The goal is to check if the drug is safe, how the body processes it, and whether food affects its absorption. This is a first step before testing the drug in people with non-alcoholic…

This early-stage study tests a single injection of HEC-151 in 81 healthy Chinese men to see if it is safe and how the body processes it. Participants receive either the drug, a placebo, or an active comparator. The goal is to gather safety data, not to treat any disease.